{
  "Variants Include": [
    {
      "Gene": "PARKIN",
      "variants": [
        {
          "HGVS": "NM_004567.3:c.182G>A; NP_004558.2:p.K48A",
          "cDNA Change": {
            "transcript": "NM_004567.3",
            "ref": "G",
            "alt": "A",
            "position": "182"
          },
          "Protein Change": {
            "ref": "K",
            "alt": "A",
            "position": "48"
          },
          "Description in input context": "c.182G>A (p.K48A)"
        },
        {
          "HGVS": "NM_004567.3:c.124C>T; NP_004558.2:p.R42P",
          "cDNA Change": {
            "transcript": "NM_004567.3",
            "ref": "C",
            "alt": "T",
            "position": "124"
          },
          "Protein Change": {
            "ref": "R",
            "alt": "P",
            "position": "42"
          },
          "Description in input context": "c.124C>T (p.R42P)"
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Autosomal recessive juvenile parkinsonism 1",
    "MONDO": "MONDO:0020048"
  },
  "Experiment Method": [
    {
      "Assay Method": "Urea unfolding experiments",
      "Material used": {
        "Material Source": "In vitro",
        "Material Name": "Parkin constructs",
        "Description": "Various parkin constructs, including wild-type and mutant forms."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_004567.3:c.182G>A; NP_004558.2:p.K48A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "partial loss-of-function",
          "Result Description": "The K48A mutation resulted in altered protein folding and reduced stability."
        },
        {
          "Variant": "NM_004567.3:c.124C>T; NP_004558.2:p.R42P",
          "Conclusion": "Abnormal",
          "Molecular Effect": "loss-of-function",
          "Result Description": "The R42P mutation caused significant structural disruption and degradation of the protein."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Multiple biological replicates were performed to ensure consistency."
      },
      "Technical replicates": {
        "Technical replicates": "Yes",
        "Description": "Each experiment was repeated multiple times for technical validation."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type parkin construct was used as a positive control."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Empty vector or non-functional constructs were used as negative controls."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "No",
        "Counts": "0"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "No",
        "Counts": "0"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "Not described in the literature."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Normal protein stability and folding patterns.",
        "Source": "Custom"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Significantly altered protein stability or folding patterns.",
        "Source": "Custom"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    },
    {
      "Assay Method": "NMR spectroscopy",
      "Material used": {
        "Material Source": "In vitro",
        "Material Name": "GB1-Ubld fusion protein",
        "Description": "The GB1-Ubld fusion protein was expressed and purified in E. coli."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_004567.3:c.124C>T; NP_004558.2:p.R42P",
          "Conclusion": "Abnormal",
          "Molecular Effect": "loss-of-function",
          "Result Description": "The R42P mutation caused a significant structural change in the GB1-Ubld fusion protein."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Multiple biological replicates were performed."
      },
      "Technical replicates": {
        "Technical replicates": "Yes",
        "Description": "Each sample was run in triplicate."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type GB1-Ubld fusion protein was used as a positive control."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Empty vector or non-functional constructs were used as negative controls."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "No",
        "Counts": "0"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "No",
        "Counts": "0"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "Not described in the literature."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Normal protein structure and stability.",
        "Source": "Custom"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Significant deviation from normal structural patterns.",
        "Source": "Custom"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    },
    {
      "Assay Method": "In vitro degradation assays",
      "Material used": {
        "Material Source": "In vitro",
        "Material Name": "Parkin constructs",
        "Description": "Various parkin constructs were subjected to in vitro degradation assays."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_004567.3:c.124C>T; NP_004558.2:p.R42P",
          "Conclusion": "Abnormal",
          "Molecular Effect": "loss-of-function",
          "Result Description": "The R42P mutation resulted in accelerated protein degradation."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Multiple biological replicates were performed."
      },
      "Technical replicates": {
        "Technical replicates": "Yes",
        "Description": "Each experiment was repeated multiple times for technical validation."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type parkin construct was used as a positive control."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Empty vector or non-functional constructs were used as negative controls."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "No",
        "Counts": "0"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "No",
        "Counts": "0"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "Not described in the literature."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Normal protein stability and degradation patterns.",
        "Source": "Custom"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Significantly altered degradation patterns.",
        "Source": "Custom"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    }
  ]
}